Guillem Caballero-Modol
Bellaterra, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Gene Therapy Overexpressing Neuregulin 1 Type I in Combination With Neuregulin 1 Type III Promotes Functional Improvement in the SOD1G93A ALS Mice.
Journal: Frontiers in neurology
Published: April 10, 2021
Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 05, 2021
Motoneuron deafferentation and gliosis occur in association with neuromuscular regressive changes during ageing in mice.
Journal: Journal of cachexia, sarcopenia and muscle
Published: April 03, 2020
Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: January 23, 2020
Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1G93A ALS mice.
Journal: Neurobiology of disease
Published: October 30, 2019
Defined neuronal populations drive fatal phenotype in a mouse model of Leigh syndrome.
Journal: eLife
Published: March 26, 2019
Neuregulin 1 Reduces Motoneuron Cell Death and Promotes Neurite Growth in an in Vitro Model of Motoneuron Degeneration.
Journal: Frontiers in cellular neuroscience
Published: September 15, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026